These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6201978)

  • 41. Epitopes on H-2Dd somatic cell mutants recognized by cytotoxic T cells.
    Potter TA; Palladino MA; Wilson DB; Rajan TV
    J Exp Med; 1983 Oct; 158(4):1061-76. PubMed ID: 6194241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
    Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
    J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MUC1 peptide epitopes associated with five different H-2 class I molecules.
    Apostolopoulos V; Haurum JS; McKenzie IF
    Eur J Immunol; 1997 Oct; 27(10):2579-87. PubMed ID: 9368613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice.
    Barra C; Pérarnau B; Gerlinger P; Lemeur M; Gillet A; Gibier P; Lemonnier FA
    J Immunol; 1989 Nov; 143(10):3117-24. PubMed ID: 2478616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H-2 class I-restricted recognition of allogeneic class I peptides.
    Kievits F; Ivanyi P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):88. PubMed ID: 8438501
    [No Abstract]   [Full Text] [Related]  

  • 46. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection.
    Seaman MS; Wang CR; Forman J
    J Immunol; 2000 Nov; 165(9):5192-201. PubMed ID: 11046052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule.
    Gulden PH; Fischer P; Sherman NE; Wang W; Engelhard VH; Shabanowitz J; Hunt DF; Pamer EG
    Immunity; 1996 Jul; 5(1):73-9. PubMed ID: 8758896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.
    Koeller D; Lieberman R; Miyazaki J; Appella E; Ozato K; Mann DW; Forman J
    J Exp Med; 1987 Sep; 166(3):744-60. PubMed ID: 2442290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective expansion of H-2 restricted cytotoxic T lymphocytes to TNP-self by injection of trinitrobenzene sulfonate.
    Shearer GM; Levy RB
    Ann N Y Acad Sci; 1982; 392():137-43. PubMed ID: 6814322
    [No Abstract]   [Full Text] [Related]  

  • 51. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The functional significance of two amino acid polymorphisms in the antigen-presenting domain of class I MHC molecules. Molecular dissection of Kbm3.
    Pullen JK; Hunt HD; Horton RM; Pease LR
    J Immunol; 1989 Sep; 143(5):1674-9. PubMed ID: 2788191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
    Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
    Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motif.
    Eberl G; Sabbatini A; Servis C; Romero P; Maryanski JL; Corradin G
    Int Immunol; 1993 Nov; 5(11):1489-92. PubMed ID: 7505110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Saturation mutagenesis of a major histocompatibility complex protein domain: identification of a single conserved amino acid important for allorecognition.
    Murray R; Hutchison CA; Frelinger JA
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3535-9. PubMed ID: 3285344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
    Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
    J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
    Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
    Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.